Acetylcholine receptor alpha-subunit mRNA is increased by ascorbic acid in cloned L5 muscle cells: Northern blot analysis and in situ hybridization by unknown
Acetylcholine Receptor a-Subunit mRNA Is Increased by 
Ascorbic Acid in Cloned L5 Muscle Cells: 
Northern Blot Analysis and In Situ Hybridization 
Ora Horovitz, David Knaack, Thomas R. Podleski, and Miriam M. Salpeter 
Section of Neurobiology and Behavior, Division of Biological Sciences, Cornell University, Ithaca, New York 14853 
Abstract.  Ascorbic acid is the major factor in brain 
extract responsible for increasing the average acetyl- 
choline receptor (AChR) site density on the cloned 
muscle cell line Ls. In the present study, we show that 
this effect of ascorbic acid requires mRNA synthesis, 
and that the mRNA level for the AChR ct-subunit is 
increased to about the same level as are the surface 
receptors.  We have found no increase in the mRNA 
levels of the B-, 7-,  and &subunits, or in the mRNAs 
of other muscle-specific proteins, such as that of light 
chain myosin 2, ot-actin, and creatine kinase. By in 
situ hybridization, we further show that the increase in 
a-mRNA in response to ascorbic acid is exclusively in 
myotubes and is located near clusters of nuclei,  mRNA 
levels for the ot-subunit in mononucleated cells are 
very low and do not significantly increase in response 
to ascorbic acid. The mononucleated cells are thus ex- 
cluded as a possible source for the increase in oL-sub- 
unit mRNA detected by Northern blot analysis. Our 
results indicate that there is a  very specific action of 
ascorbic acid on the regulation of AChR a-mRNA in 
the L5 muscle cells, and that the expression of surface 
receptors in these cells is limited by the amount of 
AChR a-subunit mRNA. 
N 
'UMEROUS studies have shown that the levels of ace- 
tylcholine receptor (AChR) 1  on the cell surface can 
be regulated in muscle cells by neural tissue and 
brain extracts (Podleski et al., 1978; Jessel et al., 1979; Con- 
nolly et al.,  1982;  Buc-Caron et al.,  1983;  Neugebauer et 
al.,  1985).  Several molecules, purified from neural tissue, 
seem to mediate this effect.  One such factor, ascorbic acid 
(176 mol wt), has been reported to increase surface AChR 
levels in the rat-derived cloned L~ muscle cell (Knaack and 
Podleski, 1985; Knaack et al., 1986). Other factors such as 
ARIA (43,000 mol wt), purified from chick brain (Usdin and 
Fischbach, 1986),  and CGRP (3,806 mol wt), a neuropep- 
tide present in many parts of the nervous system (Rosenfeld 
et al.,  1983;  Mason et al.,  1984;  Takaim et al.,  1985a,b), 
have both been reported to increase surface AChR levels in 
chick primary cells (Usdin and Fischbach, 1986;  New and 
Mudge, 1986; Fontaine et al., 1986). Although it has not yet 
been demonstrated that any of the above factors affect the 
synthesis of the AChR in vivo, they provide useful tools for 
studying the regulation of AChR synthesis. 
D. Knaack's present address is Laboratory of Molecular and Cellular Cardi- 
ology, Howard Hughes Medical Institute,  Department of Cardiology,  The 
Children's Hospital,  Harvard Medical School, Boston, MA 02115. 
1. Abbreviations  used in this paper:  AChR, acetylcholine receptor;  BGT, 
bungarotoxin. 
Since ascorbic acid was shown to increase the rate of inser- 
tion of the AChR into the cell surface membrane, without 
affecting the degradation rate of AChR or increasing overall 
total protein synthesis (Knaack and Podleski, 1985; Knaack 
et al., 1986), the work in our laboratory has concentrated on 
understanding the molecular events involved in the effect of 
ascorbic acid on the AChR. In the present study, we exam- 
ined the effect of ascorbic acid on the AChR mRNA in L5 
cells to establish the extent to which the increase in the sur- 
face AChR is transcriptionally regulated. Our results show 
that ascorbic acid induces an increase in ~-subunit-specific 
mRNA which correlates with the increased expression of 
AChR on the cell surface. Since none of the other subunit 
mRNAs are elevated, we suggest that the increased expres- 
sion of surface AChR in response to ascorbic acid is con- 
trolled by the availability of only the c¢-subunit mRNA. By 
in  situ  hybridization,  we  further  show  that  the  ascorbic 
acid-induced increase in a-subunit mRNA is not due to an 
increase in the number of AChRs producing myotubes nor 
to expression in mononucleated cells, but is a result of a net 
increase in ot-mRNA per myotube. The t~-mRNA molecules 
in the L5 cells are predominantly located over, or in the vi- 
cinity of, clusters of nuclei along the myotubes. This local- 
ization is especially pronounced in the ascorbic acid-treated 
cells where a 4.6-fold increase in t~-mRNA is expressed at 
such active nuclear clusters. 
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Cell Cultures 
L5 muscle cultures (Yaffe, 1968;  Catterall,  1976) were prepared as previ- 
ously described (Knaack and Podleski,  1985;  Neugebauer et al.,  1985). 
Briefly, L5 cells were plated at a density of 5  ×  104 ceUs/ml on either 100- 
mm tissue culture dishes containing 10 ml of medium (for RNA prepara- 
tion), or on multi-well plates containing 0.5 ml medium (for surface AChR 
studies). Cells were also plated at a density of 1-2  x  104 cells/ml on 35- 
mm culture dishes containing 2 ml of medium (for in situ hybridization). 
The growth medium was DME and 10% FCS. Under these conditions, L5 
cells fuse spontaneously starting on day 3  in culture. 
Ascorbic Acid and Rat Brain Extract Treatment 
Cells were treated, on either day 4 or on days 4 and 5 of plating, with ascor- 
bic acid (30/~g/ml of growth medium) using a freshly prepared (1 mg/ml) 
ascorbic acid solution (Knaack and Podleski, 1985) or with rat brain extract 
(540 #g/ml of growth medium; Podleski et al., 1978; Salpeter et al., 1982). 
Control cells were treated with an equal volume of PBS. Cultures were har- 
vested at different times after treatment indicated in Results. 
Actinomycin D Treatment 
Actinomycin D (Calbiochem-Behring Corp., San Diego, CA) at a final con- 
centration of 2.5 #g/ml was added to L5 cells at the same time as the ascor- 
bic acid, or at different times after ascorbic acid addition. Incubation times 
with actinomycin D were between 16 and 24 h. At the end of the incubation 
period, cells were assayed for surface AChR and c~-mRNA,  as described 
below. We, as well as others (Yaffe and Feldman, 1964;  Hartzell and Fam- 
brough,  1973),  observed that the actinomycin D treatment often caused a 
significant  detachment of  mononucleated cells with little effect  on myotubes. 
Nevertheless, in each experiment after incubation with actinomycin D, the 
cultures were examined microscopically to determine that there was no ob- 
vious decrease in myotube numbers relative to untreated cultures. 
Quantitation of Cell Surface Acetylcholine Receptor 
Surface AChR was determined by a  125I-~-bungarotoxin (125I-c~-BGT) bind- 
ing assay (Knaack and Podleski,  1985).  t25I-ot-BGT (sp act, 50-100  Ci/ 
mmol) was added to cells plated on multi-well dishes (24 wells/dish), at a 
final concentration of 20 nM. After a 30-rain incubation at room tempera- 
ture, the cell layer was rinsed several times with Hepes-buffered DME (pH 
7.4) containing 1 mg/ml BSA, and the cell~ were solubilized in 0.9 ml of 
2  M  NaOH.  Bound  t25I-BGT was determined by gamma counting. Non- 
specific binding was determined by a 15-min preincubation with 10 #M un- 
labeled oL-BGT followed by the addition of 125I-ot-BGT, as described above. 
RNA Preparation, Northern Blot, and 
Slot Blot Analysis 
Total RNA was extracted by the LiCI-urea procedure (Auffray et al., 1980). 
For Northern analysis, l0 or 20 #g total RNA was electrophoresed in 1.2% 
agarose-formaldehyde denaturing gel and transferred to GeneScreen Plus 
(New England Nuclear, Boston, MA) nylon membrane according to sup- 
pliers' instructions. Prehybridization and hybridization were performed at 
55°C in 50%  formamide, 10% dextran sulfate,  1%  SDS,  l  M  NaC1,  and 
100 #g/ml denatured salmon sperm DNA. 
For the detection of AChR t~-subunit mRNA, a 32p-labeled  RNA probe 
was used. This probe was made by transcribing and 32p-labeling the 450-bp 
Pstl  fragment of a  mouse ct-subunit-specific cDNA,  isolated  from the 
pMARod5 plasmid (Boulter et al., 1985),  and subcloning it into a pGEM3 
vector. 
The ~-, 7-,  and tS-subunits were detected by hybridization with 32p-la- 
beled nick-translated cDNA probes. Plasmids containing cDNA were pro- 
vided by J. Patrick, and J. Boulter (Salk Institute) supplied the/3- (BMB49; 
Patrick et al.,  1987) and 7-subunits (BMG419; Boulter et al.,  1986);  and 
N.  Davidson (California Institute of Technology) provided the tS-subunit 
(p6H;  LaPolla et al.,  1984). 
Hybridized blots were washed with 0.1  x  SSC (l  x  SSC  =  150 mM 
NaCl,  150 mM sodium citrate), 0.1%  SDS at 65°C. The specific mRNA 
bands were quantified by densitometric scanning of autoradiograms using 
a densitometer (LKB Instruments Inc., Gaithersburg, MD). Only exposure 
times, giving optical density values proportional to the amounts of total 
RNA applied, were used for quantification. 
For slot blot analysis, "-,5 #g of total RNA was resuspended in 10 #1 of 
formaldehyde-formamide  solution denatured at 65°C for 15 min and applied 
to GeneScreen Plus (New England Nuclear) using a BRL Hybri-slot Mani- 
fold (1052MM). After RNA application, gentle vacuum was applied for 15 
min until samples were completely adsorbed. Hybridization using a 32p_ 
labeled nick-translated a-specific cDNA (pA59) (Merlie et al.,  1983) was 
performed, as for Northern blots, in 50% formamide, 10% dextran sulfate, 
1% SDS,  1 M NaCI, and 100 #g/ml denatured salmon sperm DNA, over- 
night at 65°C. After hybridization, blots were washed for 2 h in 0.1  x  SSC, 
0.1%  SDS at 70°C. 
In Situ Hybridization 
Preparation of 3JS-labeled RNA Probe. A  1.3-kb a-subunit-specific Pstl 
cDNA fragment obtained from the pMARod5 plasmid (Boulter et al., 1986) 
was subcloned into the pGEM3 transcription vector. 35S-labeled antisense 
RNA transcripts (sp act, 0.8-1  ×  109 cpm/#g) were prepared by the Ribo- 
probe procedure (Promega Biotec,  Madison, WI) using 40 mCi/ml [35S]uri- 
dine 5'-triphosphate (SJ40383;  Amersham Corp., Arlington Heights, IL), 
and T7 polymerase. Since it was previously suggested that smaller probes 
are more efficient for in situ hybridization (Cox et al.,  1984),  the labeled 
probe was hydrolyzed with 40 mM NaHCO3/60 mM Na2CO2 (pH 10.2) at 
60°C for 38 min, which was the calculated time for obtaining 150-bp-long 
fragments (Cox et al.,  1984).  The hydrolyzed probe was ethanol precipi- 
tated,  resuspended in hybridization buffer to a  concentration of 1 ng/#l 
("-,-1  x  106 cpm/#l), and stored at  -200C for at most 2-3 d. 
Hybridization. Cells grown on 35-ram dishes, as described above, were 
fixed with a freshly prepared 4%  paraformaldehyde (pH 7.4) solution. To 
lower nonspecific  background hybridization, cultures were acetylated for 10 
min at room temperature using a mixture of 150 #1 acetic anhydride and 50 
ml of 0.1 M triethanolamine (pH 8.0). After acetylation, cells were rinsed 
4-5 times with 2  ×  SSC, and were prehybridized at 55°C for 4 h in a buffer 
containing 50% formamide, 10% dextran sulfate, 1% SDS, 100 mM DTT, 
1 M NaC1, and 100/zg/ml of each salmon sperm DNA and Escherichia  coli 
tRNA. After prehybridization, the buffer was removed, and 10/~1 of fresh 
hybridization buffer,  containing 2 ng of aSS-labeled ot-subunit-specific an- 
tisense RNA probe, preheated to 65°C for 10 min, were applied to the center 
of  each culture dish. The hybridized area was covered with an 18  x  18-mm 
coverslip. Culture dishes were placed in large, covered petri dishes and were 
hybridized at 55°C for 16-24 h in a water bath. After hybridization, cover- 
slips were removed by 2  ×  SSC, 50% formamide. Plates were washed twice 
with shaking for 30 min each, first in 2  x  SSC, 50% formamide, and then 
Figure  1.  AChR u-subunit mRNA increases in response to crude 
brain extract and ascorbic acid.  L5 ceils treated with crude brain 
extract (RBE), ascorbic acid (ASC), or PBS (CONT) on days 4 and 
5  after plating were harvested on day 7.  10/zg of total RNA,  ex- 
tracted from treated and control cells, were analyzed by Northern 
blot  hybridization  using  a  32p-labeled  u-subunit-specific  RNA 
probe (see Materials and Methods). Position of 18S rRNA is indi- 
cated. Tabulated data (below blots) report average results for four 
experiments.  Surface  AChR,  assessed on companion cultures by 
x25I-t~-BGT  binding  and  gamma  counting  (see  Materials  and 
Methods) gave an increase over control values for ascorbic acid and 
brain extract of 2.9  -1- 0.11  and 3.1  +  0.23  respectively, within the 
range of two- to sixfold previously reported (Knaack and Podleski, 
1985;  Knaack et al.,  1986;  Neugebauer et al.,  1985). 
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mRNA levels. Northern blot analysis of 10 #g total RNA from con- 
trol (CONT) or ascorbic acid-treated  (ASC) ceils as in Fig.  1, hy- 
bridized  to 32P-labeled nick-translated/3-,  3~-, and 6-subunit-spe- 
cific cDNA probes  (see Materials  and Methods).  Position of the 
18S rRNA is indicated. 
in  1  x  SSC, 50%  formamide at 55°C, and, finally,  in  1  x  SSC at room 
temperature. Cells were dehydrated through 70, 95, and 100% ethanol, and 
air dried. Duplicate plates for each condition were treated with 100 #g/ml 
RNase for 30 min at 37°C before the acetylation step, and were used as con 
trois for nonspecific binding of the probe. 
Detection of Hybridization. Autoradiograms were prepared by the flat 
substrate monolayer stripping film method to avoid artefacts caused by un 
even drying of liquid emulsion over and around individual cell contours. 
The stripping film using Ilford LA emulsion was made and applied as previ- 
ously described (Land et al.,  1977; Salpeter,  1981). Developing was for 4 
min at 20°C using DI9 developer. 
Autoradiograms were examined by both oil immersion phase microscopy 
(microscope with anoptral-contrast objectives; Reichert Scientific Instru- 
ments, Buffalo,  NY) and by scanning EM, according to the procedures pre- 
viously described (Neugebauer et al.,  1985;  Salpeter et al.,  1988).  For 
phase microscopy, nuclei of  cells in developed autoradiograms were stained 
with Harris' modified hematoxylin (Fisher Scientific, Rochester, NY), ac- 
cording to manufacturers recommendation, for 6 rain, and counterstained 
with Eosin Y (1 g in 70% ethyl alcohol plus 0.5% glacial acetic acid). Since 
it was not determined whether under the conditions used (0.2 #g probe/ml 
hybridization mixture for 16-24 h) saturation of  hybridization was achieved, 
no absolute quantitation of u-mRNA was attempted. 
Fine Structure 
Cells were fixed and prepared for transmission EM, as previously described 
(Land et al.,  1977; Salpeter et al.,  1982). 
Results 
Ascorbic Acid Treatment and Cellular 
Transcript Levels 
The effect of crude brain extract and of ascorbic acid on the 
levels of the ot-subunit mRNA is illustrated in Fig.  1. 2 Den- 
sitometric quantitation of ct-mRNA levels in four different 
RNA  preparations  from ascorbic  acid  and  brain  extract- 
treated  cultures  gave a  mean  increase  of 2.4  +  0.22  for 
ascorbic acid and 2.7  +  0.24 for rat brain extract compared 
to PBS-treated controls.  These results show that a-mRNA 
levels are increased by both brain extract and ascorbic acid, 
and that the extent of this increase is similar to the increase 
2. The data of Fig.  1 were presented in preliminary form in proceedings 
of meetings. Knaack, D., S. Admon, T.  Podleski, R. Oswald, and M.  M. 
Satpeter.  1985. Soc. Neurosci.  Abstr.  11:771; see also Knaack et al.,  1987; 
Horovitz and Salpeter,  1988. 
observed in surface AChR. Fig. 1 further shows that, as pre- 
viously reported for surface receptors, ascorbic acid induces 
the same response in c~-subunit mRNA as the crude brain ex- 
tract does. 
In contrast to the increase in AChR c~-subunit mRNA in 
response to ascorbic acid, there was no change in the levels 
of the ~- or 3,-subunit mRNAs, and there was a  slight de- 
crease  in  the  tS-subunit  mRNA  (Fig.  2).  Other  muscle- 
specific mRNAs such as a-actin, myosin light chain 2, and 
creatine phosphokinase were also not increased (not shown). 
The response to ascorbic acid was further examined by de- 
termining the time course required for the ascorbic acid-in- 
duced  changes  in  tx-mRNA and  in  surface AChR.  Using 
slot-blot analysis,  an  increase in  ot-mRNA levels was de- 
tected by 20-25 h  after ascorbic acid treatment (Fig.  3 A). 
Similarly, the earliest time that a  significant increase (1.3- 
1.5-fold) in surface AChR could be detected by ~zsI-tx-BGT 
binding and gamma counting was 20-25 h after the addition 
of ascorbic acid (Fig. 3 B). The above results show that there 
is a relatively long delay after the addition of ascorbic acid 
before any significant  increase  is  seen in  either o~-subunit 
mRNA or surface receptor. 
Ascorbic Acid Effect on AChR Requires 
mRNA Synthesis 
To determine whether the ascorbic acid-induced increase in 
surface AChR and u-subunit mRNA levels require de novo 
RNA synthesis, actinomycin D, an inhibitor of mRNA syn- 
thesis,  was added at different times after ascorbic acid.  If 
added  to  treated cultures  up to 24  h  after the  addition  of 
ascorbic  acid,  actinomycin D  completely blocked  the  in- 
crease in surface AChR (Fig. 4 A). Furthermore, no increase 
in c~-subunit mRNA was detected (data not shown). If added 
24 h  or later after ascorbic acid treatment (after some in- 
crease in surface receptor has already occurred as shown in 
Fig.  3  B),  actinomycin D  arrested any further increase in 
surface AChR levels (Fig.  4  B). 
In Situ Hybridization 
Fig.  5  and Table I  illustrate the ascorbic acid-induced  in- 
crease in ct-subunit mRNA as detected on the single cell level 
by  in  situ  hybridization.  These  results  establish  that  the 
tx-mRNA is exclusively detected in myotubes and that in both 
control and ascorbic acid-treated mononucleated cells only 
grain densities close to background can be detected. Further- 
more, in myotubes, the a-mRNA is not uniformly distrib- 
uted but is predominantly located over and in the vicinity of 
nuclear clusters. This nonuniform distribution of grains can- 
not  be because of uneven drying of the  emulsion  since a 
predried  monolayer of emulsion  was used.  A  gradient  of 
grains  is  usually  observed away from the  labeled  nuclear 
clusters (Figs.  5 B  and 6).  This gradient is variable and is 
steeper in ascorbic acid-treated cells than in controls. As Ta- 
ble I shows, treatment (for 72 h) with ascorbic acid can in- 
crease the ct-mRNA levels near and over labeled nuclei by 
4.6-fold, whereas away from nuclear clusters a smaller (1.6- 
fold) increase in ot-mRNA is detected. Although the increase 
in ct-mRNA is observed in most of the ascorbic acid-treated 
myotubes, there is a considerable cell-to-cell variation, and, 
even in the same myotube, not all areas containing nuclear 
clusters are highly labeled. 
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Figure 3.  Ascorbic acid effect on a-subunit mRNA and surface AChR. (A) The increase in mRNA for the AChR u-subunit  in L5 cells 
is plotted against time in ascorbic acid. Total mRNA for the a-subunit of AChR was determined by slot-blot hybridization using a 32P-la- 
beled nick-translated ~-subunit-specific  probe (see Materials and Methods).  Curves are normalized to midpoint of PBS control curves 
at 40 h.  PBS-treated control cells ([3); ascorbic acid-treated  cells (..).  The control and ascorbic acid data overlap at the first two data 
points. Data is average of two experiments.  (B) ~25I-a-BGT  binding to Ls myotube cell surface evaluated by gamma counting is plotted 
against time in ascorbic acid. Time 0 is day 4. All data were normalized to the midpoint of the control curve (at 40 h). PBS-treated control 
cells ([]); ascorbic acid-treated  cells (,,).  Data are from six experiments. Each time point represents one or an average of three experi- 
ments. Note that in this figure, cultures used for mRNA and AChR were not plated at the same time in contrast to those used for Fig. 1. 
In contrast to the localization of the a-mRNA around and 
over the myotube nuclei,  the  surface AChR  (labeled with 
~25I-BGT) does not show preferential localization around nu- 
clear rich areas. Grain counts from autoradiograms of ascor- 
bic acid and control cells showed a complete independence 
in the localization of AChR clusters relative to nuclei. As was 
previously shown, the AChR distribution in control L~ cells 
has very few clusters (Neugebauer et al.,  1985), and ascor- 
bic acid-treated cells have only slightly more (Knaack et al., 
1986).  We found, however, that, even after crude brain ex- 
tract, which contains considerably more clustering activity 
than ascorbic acid does (Knaack et al.,  1986),  the AChR 
clusters did not coincide with regions of nuclear clusters. 
Thus, there seems to be a redistribution of receptors, either 
in the cytoplasm before insertion into the membrane or in 
the membrane after insertion,  resulting in a distribution of 
receptor on the  myotube surface  unrelated  to the  nuclear 
clusters. 
Morphology of the Labeled Areas 
We examined the fine structure of the L5 cells to determine 
whether there are any unique specializations in the areas over 
and adjacent to nuclear clusters that might explain the ac- 
cumulation of the ~x-mRNA at these sites. The fine structure 
of the L5 cells is similar to that of the L6 cells (Land et al., 
1977; Klier et al., 1977; Podleski et al., 1979). The mononu- 
cleated cells have large nuclei and a cytoplasm with extensive 
membranous endoplasmic reticulum as well  as mitochon- 
dria. The myotubes are rich in mytochondria with only occa- 
sional and small strands of rough endoplasmic reticulum and 
relatively low levels of myofilaments with no Z bands. The 
only organelle more frequently encountered near nuclei was 
the Golgi complex. Although no quantitation was attempted, 
we saw no obvious preferential localization of other organ- 
elles, such as rough endoplasmic reticulum near the nuclei 
(Fig. 6). As previously described for rat primary cells (Sal- 
peter et al.,  1982),  treatment with brain extract causes no 
demonstrable change in the fine structure or apparent mor- 
phological differentiation in either myotubes or mononucle- 
ated cells. 
Discussion 
Ascorbic acid was shown earlier to be a major active compo- 
nent in brain extract involved in  increasing surface AChR 
levels in the Ls cloned muscle cell (Knaack and Podleski, 
1985;  Knaack et al.,  1986).  In the present study, we show 
that ascorbic acid specifically increases the mRNA for the 
c~-subunit  of the  AChR by about twofold,  with higher  in- 
creases ('~4.6-fold) in localized regions (Table I). However, 
it does not increase any of the other AChR subunit mRNAs. 
Since actinomycin D blocks the increase in both a-mRNA 
and surface AChR, the ascorbic acid-induced increase in the 
L5  cells  is  dependent  upon  de  novo  synthesis  and  is  not 
merely a posttranscriptional stabilization. However, it is not 
clear whether the synthesis required is for c~-AChR or that 
of another mRNA species. The time course required for the 
ascorbic acid action (20-25 h) raises the possibility that one 
or more intermediate steps may be involved. 
Our finding that only the a-subunit mRNA is increased is 
similar to,  but an extension of,  reports on chick primary 
muscle cells. Harris et al. (1988) showed that ARIA increases 
mRNA for the c~-subunit  in chick cells but not that for the 
3'-  and  6-subunits.  In  that  study,  the  /~-subunit  was  not 
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Figure 4.  Actinomycin D  prevents  the  ascorbic 
acid-induced  increase in surface AChR measured 
by ~25I-BGT  binding and gamma counting.  Cells 
were pretreated  with ascorbic  acid  for different 
times  (preincubation  with  ascorbic  acid)  before 
addition of actinomycin D (ASC +  ACT D). Sur- 
face AChR was assessed 16-24 h later. For all time 
points, a total treatment of at least 24 h was used 
before surface AChR was assayed. In parallel ascor- 
bic acid-treated  cells (ASC) and PBS-treated con- 
trol cells (PBS) were incubated for an equal total 
length of time (preincubation time plus 16-24 h). 
Actinomycin D treatment of control cells (PBS + 
ACT D) decreased surface receptor levels at most 
by 30% (data not shown). (A) Cells preincubated 
with ascorbic acid for up to 15 h. (B) Cells prein- 
cubated with ascorbic acid for 24,  30, and 48 h. 
Since by 24 h some increase in surface AChR is 
already produced  by ascorbic acid (see Fig. 3 B 
and also ascorbic acid columns in A), the addition 
of actinomycin D at this stage does not prevent but 
only arrests  further  increase. 
checked.  Similarly,  CGRP  also  increases  the  c~-subunit 
mRNA although other subunits were not tested (Fontaine et 
al.,  1987).  Thus,  several different factors, present in brain 
and spinal cord, stimulate specific increases in the a-subunit 
mRNA. This regulation is thus distinctly different from the 
regulation of extrajunctional receptors seen after denervation 
or  during  differentiation  when  mRNA  for  all  the  AChR 
subunits are synchronously increased (Buonanno and Mer- 
lie,  1986; Evans et al.,  1987;  Moss et al.,  1987;  Baldwin et 
al.,  1988;  Goldman et al.,  1988). 
The mechanism by which these neurally derived factors 
effect the AChR a-mRNA is not yet clear. In chick primary 
cells, CGRP rapidly increases cAMP levels at the same con- 
centrations  that  it  induces  an  approximately fourfold  in- 
crease in c~-AChR mRNA. Thus, cAMP was suggested as a 
possible second messenger in the biosynthesis of the AChR 
mRNA (Fontaine et al.,  1987).  We found that CGRP simi- 
larly induces a fivefold increase in cAMP levels in L~ cells 
and  an  increase  in  surface  receptor  of only  1.4-1.6-fold. 
However, ascorbic acid has no effect on cAMP levels in L5 
cells.  Yet ascorbic acid elevates the a-mRNA levels in L5 
cells  by  as  much  as  CGRP  does  in  the  chick  cells  and 
produces  a  much  greater  increase  in  surface AChR  than 
CGRP does (our manuscript in preparation). Therefore, not 
only different neuronal factors but also different second mes- 
senger systems seem to be involved in the regulation of the 
c~-subunit  mRNA (and thus of the surface AChR). 
In situ hybridization for the c~-subunit mRNA conclusively 
shows that ascorbic acid increases ct-mRNA levels per cell 
and that the increase is exclusively located in the myotube. 
Thus, the effect of ascorbic acid is specific for the differen- 
tiated muscle cell and is not because of an increase in the ex- 
pression of ct-mRNA in mononucleated cells. The a-mRNA 
is localized around nuclear clusters in the myotube, but the 
surface AChR is not colocalized with the ot-mRNA around the 
nuclei. 
Since Podleski et al. (1978) first showed that nerve extracts 
can stimulate the increase in surface AChR, these data, and 
Horovitz et al. AChR tr-Subunit raRNA Regulation in L5 Muscle  Cells  1827 Figure 5. In situ hybridization shows AChR c~-sub- 
unit  mRNA localization  in  vicinity of nuclei  in 
myotubes.  Light  microscope  autoradiograms  of 
L5 cells hybridized  in situ by an c~-specific mRNA 
probe (see Materials and Methods). The autoradio- 
grams were photographed with a microscope using 
an anoptral-contrast objective (Reichert Scientific 
Instruments), accounting for the white autoradio- 
graphic grains. (A) Cluster of nuclei in a myotube of 
control cells. (B) Cluster of nuclei in ascorbic acid- 
treated  cells.  (C)  Mononucleated  cells.  In each 
panel a few nuclei are marked N. Bar,  10 #m. 
subsequent confirmation in other muscle cells (Jessel et al., 
1979; Connolly et al.,  1982; Buc-Caron et al., 1983; Neuge- 
bauer et al.,  1985),  raised an apparent contradiction.  It has 
been  known  for  some  time  that  denervation,  with  its  as- 
sociated loss of muscle activity,  stimulates AChR synthesis 
and an increase in extrajunctional AChR (see Klarsfeld and 
Changeux,  1985;  Carlin et al.,  1986;  for reviews see Fam- 
brough,  1979;  Salpeter,  1987).  Furthermore,  denervation 
causes  an  increase  in  AChR  mRNA  that precedes  the  in- 
crease in extrajunctional  surface AChR (Moss et al.,  1987; 
Goldman et al.,  1988). Thus, nerve factors would not be ex- 
pected to cause an increase in AChR. However, muscle activ- 
The Journal of Cell Biology, Volume 108, 1989  1828 Table I.  The Effect of Ascorbic Acid on oe-mRNA Levels 
in L5 Muscle Cells as Determined by In Situ Hybridization 
+ Ascorbic  Ascorbic 
Location  Control  acid  acid/control 
In mononucleated 
myoblasts  1.0  +  0.17  1.2  +  0.09  1.2 
In myotubes on and 
around nuclei  2.2  +  0.33  10.0  +  0.83  4.6 
In myotubes away 
from nuclei  1.1  -i- 0.13  1.8  +  0.3  1.6 
Data normalized to myoblast grain density, which was 1.3 grains/39 #rn 2. All 
these values are after subtracting  background,  which was on average 1 grain/ 
39 #m  2. Cultures  treated with RNase before hybridization  had no label above 
background.  Cells were dosed with ascorbic acid on day 4 and fixed on day 7. 
ity does not significantly  affect  junctional AChR densities, as 
evidenced by the high AChR levels maintained at the in- 
nervated neuromuscular junction in electrically active mus- 
cle  (for review,  see Salpeter and  Loring,  1985).  Specific 
mRNAs  for the  AChR are  also higher near the junction 
(Merlie and Sanes, 1985; Witzemann et al., 1987; Fontaine 
et al., 1988). These observations suggest that different  mech- 
anisms can be involved in regulating local levels of surface 
AChR. It is possible that factors released at the neuromuscu- 
lar junctions maintain the high junctional AChR levels  in 
electrically active muscle. Although none of the neural fac- 
tors shown to regulate AChR levels in vitro have yet been 
conclusively identified as  being  released  at  the junction, 
these factors do allow us to study the different steps  in the 
regulation of AChR synthesis in different muscle cells (see 
also Horovitz et al.,  1989). 
In this study, we have demonstrated that brain extract and 
ascorbic acid-induced increase  in surface AChR are cor- 
related with an increase in a-subunit mRNA on single myo- 
tube level, suggesting that surface AChR in response to these 
factors is regulated by c~-subunit transcript availability.  Fur- 
thermore, since the increase in surface AChR is dependent 
on de novo RNA synthesis, a transcriptional regulation is in- 
dicated. 
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Note Added in Proof. Since this manuscript was submitted, a report by D. A. 
Harris, D. L. Falls, and G. D. Fischbach was published (Nature  (Lond.). 
1988.337:173-176.  This paper similarly shows that a selective localization 
of AChR ot-subunit mRNA exists over nuclear clusters in chick muscle 
treated with ARIA and that not all nuclei are equally involved. That report 
differs from ours in that it found a coiocalization between surface AChR 
clusters and mRNA concentrations, and the magnitude of the increase in 
local mRNA density is less than that reported in our Table I. These differ- 
ences may be because of  the different muscle species  or neural factors used. 
Figure 6  Gradient of o~-mRNA seen in SEM autoradiogram.  Scanning EM autoradiogram of an L5  myotube hybridized in situ with an 
oe-AChR-specific probe as in Fig.  5.  Nuclei can be seen in this preparation as circular craters  (a few marked N).  Edge of cell marked 
with caret.  Note heavy label over and  in the vicinity of nuclei with marked  gradient away  from the nuclear cluster.  Bar,  10 #m. 
Horovitz  et al. AChR tr-Subunit mRNA Regulation in Lj Muscle Cells  1829 Figure  7.  Fine structure of L5 cells is not altered by brain factor.  Electron micrograph of L5 myotubes at region of nuclear clusters (to 
be compared with Fig. 8 without nuclei). (A and B) Control cells. (C) Cells treated with a partially purified low molecular weight active 
fraction of brain extract such as shown to contain ascorbic acid (Knaack and Podleski, 1985;  Neugebauer et al., 1985).  A greater than 
twofold increase in surface AChR had been obtained in parallel cultures after this treatment. Note lack of unique specialization in region 
of nuclei except for pronounced Golgi complex (G). Strands of rough endoplasmic reticulum (arrows)  are sparsely distributed. Myofila- 
merits (F) are not as developed in Ls cells as in primary cells and lack Z bands (see also Podleski et al.,  1979;  Salpeter et al., 1982). 
Cells treated with crude brain extract have a similar appearance. Bar,  10 #m. 
The Journal of Cell Biology, Volume 108, 1989  1830 Figure 8.  Fine structure of L~ myotubes does not differ in regions with and without nuclear clusters.  As in Fig. 7, A is from control cul- 
tures, and B is from cultures treated with the low molecular weight brain extract fraction. Figs. 7 and 8 show that there is no significant 
difference in fine structure between cells near or away from nuclear clusters,  nor between control and brain extract-treated cells. 
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